CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION · Pharmaceuticals

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 4

Pharmacy

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Medical/Disease Research/Clinical Labs

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Trade (domestic/foreign)

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Health Issues

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.